Cellebrite DI
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exp… Read more
Cellebrite DI (CLBT) - Total Assets
Latest total assets as of December 2025: $938.85 Million USD
Based on the latest financial reports, Cellebrite DI (CLBT) holds total assets worth $938.85 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cellebrite DI - Total Assets Trend (2019–2025)
This chart illustrates how Cellebrite DI’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cellebrite DI - Asset Composition Analysis
Current Asset Composition (December 2025)
Cellebrite DI's total assets of $938.85 Million consist of 61.3% current assets and 38.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.3% |
| Accounts Receivable | $104.97 Million | 11.2% |
| Inventory | $7.60 Million | 0.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $81.47 Million | 8.7% |
| Goodwill | $119.56 Million | 12.7% |
Asset Composition Trend (2019–2025)
This chart illustrates how Cellebrite DI's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cellebrite DI's current assets represent 61.3% of total assets in 2025, a decrease from 93.5% in 2019.
- Cash Position: Cash and equivalents constituted 13.3% of total assets in 2025, down from 27.3% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 20.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 12.7% of total assets.
Cellebrite DI Competitors by Total Assets
Key competitors of Cellebrite DI based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Eastcompeace Technology Co Ltd
SHE:002017
|
China | CN¥2.97 Billion |
|
Wiscom System Co Ltd
SHE:002090
|
China | CN¥3.17 Billion |
|
Topsec Technologies Group Inc
SHE:002212
|
China | CN¥10.79 Billion |
|
Focus Technology Co Ltd
SHE:002315
|
China | CN¥4.27 Billion |
|
Beijing Venustech Inc
SHE:002439
|
China | CN¥13.16 Billion |
|
Maxvision Technology Corp
SHE:002990
|
China | CN¥3.74 Billion |
|
OpenSys M Bhd
KLSE:0040
|
Malaysia | RM129.25 Million |
|
Managepay Systems Bhd
KLSE:0156
|
Malaysia | RM86.24 Million |
Cellebrite DI - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Cellebrite DI generates 0.51x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Cellebrite DI generates $8.34 in net profit.
Cellebrite DI - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.56 | 1.92 | 2.14 |
| Quick Ratio | 1.54 | 1.89 | 2.11 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $206.19 Million | $ 272.09 Million | $ 168.42 Million |
Cellebrite DI - Advanced Valuation Insights
This section examines the relationship between Cellebrite DI's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.46 |
| Latest Market Cap to Assets Ratio | 1.95 |
| Asset Growth Rate (YoY) | 36.0% |
| Total Assets | $938.85 Million |
| Market Capitalization | $1.83 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Cellebrite DI's assets above their book value (1.95 x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Cellebrite DI's assets grew by 36.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Cellebrite DI (2019–2025)
The table below shows the annual total assets of Cellebrite DI from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $938.85 Million | +35.95% |
| 2024-12-31 | $690.57 Million | +29.59% |
| 2023-12-31 | $532.88 Million | +32.13% |
| 2022-12-31 | $403.29 Million | +18.69% |
| 2021-12-31 | $339.78 Million | -6.75% |
| 2020-12-31 | $364.39 Million | +30.03% |
| 2019-12-31 | $280.24 Million | -- |